neutral
Recently
Shadowfax listing draws focus on execution beyond debut day
Shadowfax listed below expectations as GMP stayed weak, yet analysts believe its scale, partnerships, and unit economics could support recovery for long term investors.
Shadowfax Technologies debuted on NSE and BSE amid volatile market conditions, with shares listing below issue expectations. Investors tracked GMP, allotment trends, and subscription data closely. Analysts noted pressure from valuation concerns and competitive logistics margins. However, the company’s extensive last mile network, strong ecommerce partnerships, and improving unit economics keep long term growth prospects intact despite near term listing disappointment for patient investors nationally.